×
Download Brochure

About the Bioprocessing Summit Europe

The Bioprocessing Summit Europe brings together 500+ bioproduction, analytical and formulation professionals to advance the manufacture, quality and control of biological and genetic therapies. This 3-day, 10 track meeting has quickly become a premier meeting in the European bioprocessing calendar and is regarded by many as “the fastest growing bioprocessing meeting in Europe” following record growth in 2022 – 350 to 500+ attendees - and a sold out Exhibit Hall.

We look forward to seeing you in Barcelona, or online, 14-16 March 2023, with expanded content on cell and gene therapy CMC and manufacturing, educational training seminars and a vastly bigger Exhibit Hall.

500+ Attendees
150+ Speakers
10 Conferences
4 Training Seminars

PLENARY KEYNOTES

EMERGING MODALITIES, PLATFORMS, AND TECHNOLOGIES – FROM mRNA TO PROTEINS

Gregory Troiano

KEYNOTE PRESENTATION:
Overcoming CMC and Supply Chain Challenges for mRNA Technologies

Gregory Troiano
Chief Manufacturing Officer, mRNA Center of Excellence, Sanofi

Sophia Hober

KEYNOTE PRESENTATION:
Affinity Proteins for Biotechnological and Medical Purposes

Sophia Hober, PhD
Professor, School of Biotechnology, KTH Royal Institute of Technology

TRACK KEYNOTE SPEAKERS

Gyun Min Lee, PhD

Gyun Min Lee, PhD
Professor, Cell and Developmental Biology, KAIST, Korea

Arun Alphonse Ignatius, PhD

Arun Alphonse Ignatius, PhD
Director, Drug Product Sciences, Macrogenics, Inc., USA

Richard D. Braatz, PhD

Richard D. Braatz, PhD
Edwin R. Gilliland Professor, Chemical Engineering, Massachusetts Institute of Technology

Yves Durocher, PhD

Yves Durocher, PhD
Research Officer & Head, Mammalian Cell Expression, National Research Council Canada

Vered Caplan

Vered Caplan
CEO, Orgenesis, Inc.

James Reilly

James Reilly
Associate Director, Regeneron Pharmaceuticals Inc.

Ayda S. Mayer, PhD

Ayda S. Mayer, PhD
Executive Director, Vector Core, REGENXBIO, Inc

Florence Salmon, PhD

Florence Salmon, PhD
Vice President, Regulatory Affairs and Preclinical Development, Ridgeline Discovery

Dan Bach Kristensen, PhD

Dan Bach Kristensen, PhD
Principal Scientist, Symphogen, Denmark

James Warren, PhD

James Warren, PhD
Vice President, Pharmaceutical Development, Ultragenyx Pharmaceutical



Health and Safety Protocols

Connect With Us

MEETING SUGGESTIONS

For meeting questions or suggestions, please contact:

Dan Barry
Senior Conference Director
Cambridge Healthtech Institute
dbarry@healthtech.com

PARTNERING & SPONSORSHIP

For partnering and sponsorship info, please contact:

COMPANIES A-K
Phillip Zakim-Yacouby

Associate Business Development Director
+1-857-214-2246
pzakim-yacouby@internetofbusiness.com

COMPANIES L-Z
Jon Stroup
Sr. Business Development Manager
781-972-5483
jstroup@healthtech.com

MEDIA & ASSOCIATION

For media and association partnerships, please contact:

Christine Benners
Sr. Marketing Manager
Cambridge Healthtech Institute
+1 781.247.1820
cbenners@healthtech.com